On July 31, 2018 Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, reported that William G. Rice, Chairman, Ph.D., President and Chief Executive Officer, and Gregory K. Chow, Senior Vice President and Chief Financial Officer, will participate at the Global Congress on Oncology & Cancer in Valencia, Spain (Press release, Aptose Biosciences, JUL 31, 2018, View Source;p=RssLanding&cat=news&id=2360915 [SID1234527973]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Rice will deliver a keynote presentation that provides a scientific overview of CG-806, including pre-clinical mechanistic data and comparison to competitor agents.

Time: 11:40 a.m. CEST
Date: Thursday, August 2, 2018
Location: Sercotel, Sorolla Palace Hotel, Valencia, Spain